Giovedì, 20 Settembre 2018

Turin court rejects appeal of stem-cell therapy


Turin, March 11 - The Turin Appeals Court on
Monday rejected a plea for a controversial form of stem-celll
therapy to be used on a sufferer of a fatal inherited
neurodegenerative disease called Niemann-Pick syndrome.
Erika Bonavita was barred last year from receiving the
controversial stem cell therapy patented by the Stamina
The treatment has been under scrutiny by the Italian
Pharmaceutical Agency (AIFA) and sparked several lawsuits by
disease sufferers seeking the therapy.
Bonavita's father Luigi, who appealed on her behalf, won a
court case for his son who suffers from the same illness,
Salvatore Bonavita, on March 7 allowing him to receive the
It involves inoculating the patient with biological
material, sometimes his or her own and sometimes from other
"Their illness is the same, problems the same...obviously
the judges think that there are those who have the right to
treatment and who don't," Luigi Bonavita said.

© Riproduzione riservata

* Campi obbligatori

Immagine non superiore a 5Mb (Formati permessi: JPG, JPEG, PNG)
Video non superiore a 10Mb (Formati permessi: MP4, MOV, M4V)


Accedi con il tuo account Facebook

Login con

Login con Facebook